PharMerica CORP Comprehensive Income
PharMerica CORP reported Comprehensive Income of $23.40 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-02-09
- PharMerica CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-12-31 was $7.90M.
- PharMerica CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was $4.80M.
- PharMerica CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was $23.40M, a 21.88% increase from fiscal 2010.
- PharMerica CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was $19.20M, a 57.33% decline from fiscal 2009.
- PharMerica CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2009 was $45.00M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2011-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-09 | $12.70M derived: sum of 2 quarters · filed 2012-02-09 | $23.40M 10-K · filed 2012-02-09 | |
| 2011-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $15.50M 10-Q · filed 2011-11-03 | ||
| 2011-06-30 | $10.70M 10-Q · filed 2011-08-04 | |||
| 2010-12-31 | $19.20M 10-K · filed 2012-02-09 | |||
| 2009-12-31 | $45.00M 10-K · filed 2012-02-09 |